Skip to Main Content

Paper Details

Presurgical <sup>68</sup>Ga-PSMA-11 Positron Emission Tomography for Biochemical Recurrence Risk Assessment: A Follow-up Analysis of a Multicenter Prospective Phase 3 Imaging Trial.
Eur Urol
2
2023
BCR, CAPRA, Cancer of the Prostate, Ga, PCa, PSA, PSMA, Patients, extraprostatic disease, patients, prostate cancer, prostate-specific antigen, prostate-specific membrane antigen
Author NameAffiliation
Andrei GafitaUniversity of California Los Angeles
Kathleen NguyenUniversity of California Los Angeles
Robert E ReiterInstitute of Urologic Oncology, University of California Los Angeles, USA Jonsson Comprehensive Cancer Center
Johannes CzerninUniversity of California Los Angeles, USA Institute of Urologic Oncology
Thomas A HopeUniversity of California San Francisco, USA Helen Diller Family Comprehensive Cancer Center
Jeremie CalaisUniversity of California Los Angeles, USA Institute of Urologic Oncology
  • 1 - 6

Datasets